Is Yunhong CTI a Good Consumer Stock to Buy?

NASDAQ: CTIB | CTI Industries Corporation News, Ratings, and Charts

CTIB – Novelty products manufacturer Yunhong CTI (CTIB) is among the leading producers of foil balloons and other party items. So, given the company’s robust financials and solid growth attributes, is CTIB worth adding to one’s portfolio? Let’s find out.

Yunhong CTI Ltd. (CTIB) in Lake Barrington, Ill., is one of the leading manufacturers and marketers of foil balloons and produces laminated and printed films for commercial uses. In addition, the company distributes Candy Blossoms and other gift items and markets its products throughout the United States and in several other countries.

The company’s stock has gained 11.4% in price over the past year and 9.6% over the past six months. However, CTIB is currently trading 59% below its 52-week high of $5, which it hit on February 23, 2021.

Given its competitive landscape and the upcoming holiday season, we think the company should witness a rise in demand for its party products line and an overall boost to its revenue. Furthermore, given CTIB’s robust financials, the stock could witness significant upside in the near term.

Here’s what could shape CTIB’s performance in the near term:

Strong Financials

For the second quarter, ended June 30, 2021, CTIB’s revenue increased 10.1% year-over-year to $6.33 billion. Its operating income came in at $2.86 billion, compared to a $962.08 million operating loss in the prior-year quarter. The company reported $1.78 billion in net income, compared to a $1.52 billion net loss in the second quarter of 2020. In addition, its EPS amounted to $0.12, compared to a $0.41 loss per share during the same period last year.

Discounted Valuation

In terms of its trailing-12-months Price/Cash Flow, the stock is currently trading at 6.22x, which is 44.2% lower than the 11.13x industry average. Also, its 0.46x trailing-12-months Price/Sales multiple is 63.9% lower than the 1.27x industry average. Also, CTIB’s 1.15x trailing-12-months EV/Sales  is 24.1% lower than the 1.52x industry average.

Consensus Rating and Price Target Indicate Potential Upside

The only Wall Street analysts providing a rating for the stock rated it a Buy. Closing yesterday’s trading session at $2.05, the $7 average price target represents a potential 241.4% upside.

Bottom Line

CTIB could see significant demand for its products and consistent growth in the coming months, thanks to the forthcoming holiday season. Moreover, its strong fundamentals and favorable analyst estimates should instill investors with hope regarding the stock. Thus, we think the stock could be a good bet at its current, discounted valuation.

 


CTIB shares were trading at $2.01 per share on Wednesday morning, down $0.04 (-1.95%). Year-to-date, CTIB has gained 16.86%, versus a 23.11% rise in the benchmark S&P 500 index during the same period.


About the Author: Pragya Pandey


Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CTIBGet RatingGet RatingGet Rating
MGDDYGet RatingGet RatingGet Rating
BRDCYGet RatingGet RatingGet Rating
LKQGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Low Could Stocks Go?

The S&P 500 (SPY) is starting to test key support levels for the first time since November 2023 given continuing signs that Fed rate cuts are getting pushed further and further into the future. This begs the question of “how low could stocks go?” 44 year investment veteran Steve Reitmeister does his level best to answer that question including a trading plan and top picks to stay one step ahead of the market. Read on below for the full story...

3 Biotech Stocks to Buy to Power Through April

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading...

Check out These 3 Internet Stocks for Potential Gains

Amplified internet usage, technological advancements, and a rising digital transformation worldwide have driven the internet industry rapidly. To that end, quality internet stocks Wix.com (WIX), Tripadvisor (TRIP), and Yelp (YELP) could be solid buys now. Read on…

Top 3 Financial Services Stocks With Unstoppable Momentum

The financial services sector is set for solid growth owing to global economic trends, technological advancements making digital services more accessible, and changing consumer preferences.Therefore, investors could consider buying fundamentally strong financial services stocks Broadridge Financial Solutions (BR), Banco Macro (BMA), and Yiren Digital (YRD) as they look well-positioned to continue their momentum. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More CTI Industries Corporation (CTIB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CTIB News